Lepidoglyphus Destructor

2 trials

Filter these 2 trials by condition, phase, country and more.

Open in Search →

2 Registered trials

0 Recruiting

1 Completed trials

3 Sponsors

1 Countries

Phase II

Phase II: 2

Sponsors using this IMP

Advanced Outcomes Research S.L. 1 Asac Pharmaceutical Inmunology S.A. 1 Diater Laboratorio De Diagnostico Y Aplicaciones Terapeuticas S.A. 1

All trials

2 total

In vivo biological standardization of Lepidoglyphus destructor allergen extract Pending

2025-520753-37-00 Phase II 1 country Advanced Outcomes Research S.L.; Asac Pharmaceutical Inmunology S.A.
BIOLOGICAL STANDARDISATION OF ALLERGENIC EXTRACTS OF MITES TO DETERMINE BIOLOGICAL ACTIVITY (IN HEP UNITS) IN SENSITIVISED PATIENTS. Ended

2024-513834-40-01 Phase II 1 country Diater Laboratorio De Diagnostico Y Aplicaciones Terapeuticas S.A.

Showing 1–2 of 2 trials

← All drugs A–Z